Prostate Cancer Theranostics: Concurrent Approvals by the Food and Drug Administration of the First Diagnostic Imaging Drug Indicated to Select Patients for a Paired Radioligand Therapeutic Drug.

Hofling, A Alex; Fotenos, Anthony F; Niu, Gang; Fallah, Jaleh; Agrawal, Sundeep; Wang, Sue-Jane; Marzella, Libero

Hofling, A Alex; Fotenos, Anthony F; Niu, Gang; Fallah, Jaleh; Agrawal, Sundeep; Wang, Sue-Jane; Marzella, Libero.

Affiliation

Hofling AA; Division of Imaging and Radiation Medicine, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland; august.hofling@fda.hhs.gov.
Fotenos AF; Division of Imaging and Radiation Medicine, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.
Niu G; Division of Imaging and Radiation Medicine, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.
Fallah J; Division of Oncology 1, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland; and.
Agrawal S; Division of Oncology 1, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland; and.
Wang SJ; Division of Biometrics I, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.
Marzella L; Division of Imaging and Radiation Medicine, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.

J Nucl Med ; 63(11): 1642-1643, 2022 11.

Article de En | MEDLINE | ID: mdl-35798555

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la prostate / Médecine de précision Type d'étude: Diagnostic_studies Limites: Humans / Male Pays/Région comme sujet: America do norte Langue: En Journal: J Nucl Med Année: 2022 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google